|
|
|
|
||
Re: Celgene's track record since February 2018 Great summary but wrong conclusion Moran. Reworded: Celgene's assets are sufficient to sustain continued EPS CAGR and accordingly did not require a merger with BMY. Only BMY needed this merger together with the elderly board of Celgene who should have retired a decade ago. |
return to message board, top of board |